Anatolian Journal of Cardiology最新文献

Background: Hypertrophic cardiomyopathy (HCM) is a complex myocardial disorder with heterogeneous clinical presentations and structural manifestations. This study aimed to assess the distribution, clinical characteristics, and diagnostic approaches in a regional cohort of patients with HCM.

Methods: Patients diagnosed with HCM at a tertiary cardiomyopathy clinic between October 2021 and November 2024 were retrospectively analyzed. Patients were classified into obstructive, latent obstructive, non-obstructive, or apical phenotypes based on clinical and imaging findings. Comprehensive demographic, clinical, and imaging data were collected for detailed analysis, providing valuable insights into the phenotypic diversity of HCM.

Results: The cohort included 701 patients with a median age of 53 years of whom 68% were male. The phenotypic distribution comprised 9.3% apical, 38.1% non-obstructive, 32.5% resting obstructive, and 20.1% latent obstructive HCM. Implantable cardioverter-defibrillator implantation was more common in obstructive phenotypes, particularly in the latent obstructive group. Although late gadolinium enhancement (LGE) was more frequently observed in apical HCM, post-hoc analysis showed no significant difference in prevalence across subgroups. In contrast, LGE extent was significantly greater in the apical group. Genetic testing, performed in 32% of patients, revealed a 44% positivity rate, with MYBPC3 and MYH7 being the most commonly detected mutations. The overall mortality rate was 2.8%, with heart failure identified as the leading cause of death.

Conclusion: In this large regional cohort of HCM patients, obstructive and non-obstructive phenotypes were predominant, with a notable burden of genetic mutations and a low overall mortality rate primarily driven by heart failure. These findings emphasize the clinical heterogeneity of HCM and highlight the importance of comprehensive diagnostic evaluation.

Background: Atrial septal defect closure can be performed surgically or via transcatheter intervention, yet comparative outcomes remain inconsistent between children and adults. This review synthesizes observational evidence to evaluate procedural success, complications, and periprocedural characteristics across both populations.

Methods: A systematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines was conducted, including 36 observational studies published through 2024. Study quality was assessed using the Newcastle-Ottawa Scale. Random effects models were applied, with subgroup analyses by age and procedure type. Publication bias was examined using funnel plots and Egger's test.

Results: The pooled procedural success rate was 95% (95% CI: 92%-97%; I² = 90.2%). Among children, raw procedural success was 87% (1445/1656) for transcatheter closure and 99% (505/510) with surgery. In adults, transcatheter closure achieved 97% (95% CI: 90%-99%), whereas surgery reached 98% (95% CI: 70%-100%). Transcatheter closure resulted in shorter hospitalization (mean difference: -3.86 days, 95% CI: -6.03 to -1.69; P = .0004) and fewer major complications (risk ratio: 0.58, 95% CI: 0.39-0.86; P = .006). Sensitivity analysis restricted to high-quality studies (n = 12) remained consistent. Egger's regression did not indicate significant publication bias (P = .069).

Conclusion: Both approaches provide high closure success, yet transcatheter intervention offers lower complication rates and faster recovery, particularly in anatomically suitable patients. These findings support individualized treatment selection based on age, anatomy, and institutional experience.